Management Team

Henry Ji, PhD
Henry Ji, PhDPresident and CEO

Dr. Ji is a successful life scientist executive, having co-founded Sorrento Therapeutics in January 2006, where he currently serves as President and Chief Executive Officer. In 2002, Dr. Ji founded and was President of BioVintage, a biopharmaceutical company. From 2001 to 2002, Dr. Ji served as VP of Strategic Alliances at CombiMatrix, and was responsible for its strategic technology alliances. From 1999 to 2001, Dr. Ji served as Director of Business Development, and in 2001 as VP at Stratagene (later acquired by Agilent Technologies), a biotechnology company. In 1997, Dr. Ji co-founded Stratagene Genomics, a wholly-owned subsidiary of Stratagene Corporation, and served as its President and Chief Executive Officer from its founding until 1999. Dr. Ji obtained his PhD in Animal Physiology from the University of Minnesota and a B.S. in Biochemistry from Fudan University.

Robert Allen, PhD
Robert Allen, PhDChief Science Officer

Dr. Allen is an accomplished scientist executive with over 15 years of experience in the biotechnology industry leading research, preclinical development, and early clinical manufacturing of antiviral and anti-cancer therapeutics.  He is currently also serving as the Senior Vice President, Antiviral and Immunotherapy at Sorrento Therapeutics. Prior to joining Sorrento, Dr. Allen served as Scientific Director of the Oregon Translational Research and Development Institute (OTRADI), collaborating with industry and academic partners on drug discovery and candidate profiling campaigns targeting hematologic cancers, solid tumors, and infectious disease pathogens. Before this, he developed discovery programs at SIGA Technologies that identified direct-acting antivirals targeting viruses in the bunyavirus and filovirus families as well as host-directed countermeasures against a broad spectrum of human viruses and obligate intracellular bacteria. He holds a Ph.D. in Microbiology from Columbia University Vagelos College of Physicians and Surgeons and a Masters in Applied Biology from Georgia Institute of Technology.

Timothy Brauns, MBA
Timothy Brauns, MBAVice President, Head of Operations

Mr. Brauns brings tested and diverse operational experience in the life sciences field over the last 25 years gained in the academic hospital environment and in biotech and medical device companies and medical philanthropies. Prior to joining SmartPharm, Mr. Brauns was the associate director of the Vaccine and Immunotherapy Center (VIC) at the Massachusetts General Hospital (MGH), where over a five-year period he helped to double the funding of the center, including landing key STTR grants and other contracts for support of preclinical life science technologies and guiding four preclinical technologies toward development partnerships. Before his work with VIC, he held positions as vice president of strategic planning for Boston BioCom, a biotechnology company; vice president of marketing and communication for BL Healthcare, a home health monitoring technology company; assistant director of the international program in the Center for the Integration of Medicine and Innovative Technology (CIMIT) at MGH; and director of program development at the Adelson Medical Research Foundation.

Mr. Brauns brings special skills in the development and management of “distributed development” of new life science technologies through cross-disciplinary, inter-institutional, industry-academic teams, and in sponsored program developing, assisting organizations he was part of in securing over $60 million in grants and contracts from a broad range of federal and private funding organizations.